Evidence map›Paper›PMID 38427277›Full record

ArticleCommunity mental health journal2025

Antipsychotics and Identity: The Adverse Effect No One is Talking About.

M Conneely, D Roe, I Hasson-Ohayon, G H M Pijnenborg, L van der Meer, H Speyer

Abstract read
PubMed Publisher
In one paragraph

Article in Community mental health journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M ConneelyDivision of Psychiatry, University College London, Maple House, W1T 7BN, London, UK. m.conneely@ucl.ac.uk.ORCID 0000-0001-8326-4498
D RoeDepartment of Psychology, Bar-Ilan University, Ramat-Gan, Israel.ORCID 0000-0002-6197-0989
I Hasson-OhayonDepartment of Psychology, Bar-Ilan University, Ramat-Gan, Israel.ORCID 0000-0002-5618-019X
G H M PijnenborgDepartment of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, Netherlands.ORCID 0000-0002-1461-0649
L van der MeerDepartment of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, Netherlands.
H SpeyerMental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark.ORCID 0000-0002-7437-6102

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

People who take antipsychotics, and people who are prescribed antipsychotics without taking them, experience effects which are not frequently discussed: effects on their identity and sense of self. Qualitative research indicates the relationship between taking APs and identity is multilayered, and changeable. Taking APs can restore people to their earlier, pre-symptom sense of self. Being prescribed and taking APs can also, on the other hand, be experienced as damaging, erasing and dulling people's sense of who they are. This complexity deserves exploration in clinical practice, which we believe is currently not done routinely. More work is needed to understand whether, and how, the relationship between identity and APs is being addressed. We outline the importance of having discussions in a clinical space around identity, and a sense of agency, on the grounds that true recovery-oriented care, which enacts shared decision-making principles, demands it. Further, we argue that it will allow for better therapeutic alliance and trust to be forged between clinician and client, ultimately leading to better care.

Indexed as

Antipsychotic AgentsSelf ConceptHumansQualitative ResearchAntipsychotic AgentsAntipsychoticsIdentityMedicationNeuroleptic MedicationPsychosisSchizophreniaSelf-stigma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.